The Enterprise Value as of November 2024 (TTM) for Orgenesis Inc. (ORGS) is 23.35M

According to Orgenesis Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 23.35M. This represents a change of -89.54% compared to the average of 223.18M of the last 4 quarters.

Orgenesis Inc. (ORGS) Historical Enterprise Value (quarterly & annually)

How has ORGS Enterprise Value performed in the past?

The mean historical Enterprise Value of Orgenesis Inc. over the last ten years is 533.06M. The current 23.35M Enterprise Value has changed 338.00% with respect to the historical average. Over the past ten years (40 quarters), ORGS's Enterprise Value was at its highest in in the March 2021 quarter at 1.36B. The Enterprise Value was at its lowest in in the December 2023 quarter at 180.11M.

Orgenesis Inc. (ORGS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Orgenesis Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Orgenesis Inc. (ORGS) Average Enterprise Value

How has ORGS Enterprise Value performed in the past?

The current Enterprise Value of Orgenesis Inc. (ORGS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Orgenesis Inc. (ORGS) Enterprise Value vs. Peers

How is ORGS’s Enterprise Value compared to its peers?

Orgenesis Inc.’s Enterprise Value is greater than TFF Pharmaceuticals, Inc. (-1374952.00), less than Oncorus, Inc. (42.71M), greater than Quoin Pharmaceuticals, Ltd. (-162664.00), greater than Apexigen, Inc. (-5121682.00), less than Aerovate Therapeutics, Inc. (46.23M), greater than Adagene Inc. (22.22M), less than Acrivon Therapeutics, Inc. Common Stock (163.47M), less than Rezolute, Inc. (276.11M), greater than AN2 Therapeutics, Inc. (6.48M), less than NeuroBo Pharmaceuticals, Inc. (0), greater than Indaptus Therapeutics, Inc. (-1095056.00), greater than Pasithea Therapeutics Corp. (2.92M), greater than Lixte Biotechnology Holdings, Inc. (-5435245.00), greater than Eliem Therapeutics, Inc. (2.03M), less than Design Therapeutics, Inc. (119.64M), less than Tango Therapeutics, Inc. (290.40M), less than Talaris Therapeutics, Inc. (405.56M), less than Achilles Therapeutics plc (50.00M), greater than null (-38865958.00),

Build a custom stock screener for Orgenesis Inc. (ORGS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orgenesis Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Orgenesis Inc. (ORGS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Orgenesis Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.